| [1] |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3)：209-249.
|
| [2] |
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023 [J]. CA Cancer J Clin, 2023, 73(1)：17-48.
|
| [3] |
Ashworth TR. A case of cancer in which cells similar to those in the tumours were seen in the blood after death [J]. Aust Med J, 1869, 14：146.
|
| [4] |
Deng Z, Wu S, Wang Y, et al. Circulating tumor cell isolation for cancer diagnosis and prognosis [J]. EBioMedicine, 2022, 83：104237.
|
| [5] |
Moon DH, Lindsay DP, Hong S, et al. Clinical indications for, and the future of, circulating tumor cells [J]. Adv Drug Deliv Rev, 2018, 125：143-150.
|
| [6] |
Feng Z, Wu J, Lu Y, et al. Circulating tumor cells in the early detection of human cancers [J]. Int J Biol Sci, 2022, 18(8)：3251-3265.
|
| [7] |
Ju S, Chen C, Zhang J, et al. Detection of circulating tumor cells: opportunities and challenges [J]. Biomark Res, 2022, 10(1)：58.
|
| [8] |
Harigopal M, Kowalski D, Vosoughi A. Enumeration and molecular characterization of circulating tumor cells as an innovative tool for companion diagnostics in breast cancer [J]. Expert Rev Mol Diagn, 2020, 20(8)：815-828.
|
| [9] |
Zeng H, Veeramootoo JS, Ma G, et al. Clinical value and feasibility of ISET in detecting circulating tumor cells in early breast cancer [J]. Transl Cancer Res, 2020, 9(7)：4297-4305.
|
| [10] |
Heidrich I, Ačkar L, Mossahebi Mohammadi P, et al. Liquid biopsies: potential and challenges [J]. Int J Cancer, 2021, 148(3)：528-545.
|
| [11] |
Cueva Bañuelos JF, Rodríguez López C, Cortegoso Mosquera A, et al. Clinical relevance and therapeutic application of CTCs in advanced breast cancer [J]. Adv Exp Med Biol, 2020, 1220: 147-164.
|
| [12] |
Hench IB, Hench J, Tolnay M. Liquid biopsy in clinical management of breast, lung, and colorectal cancer [J]. Front Med (Lausanne), 2018, 5：9.
|
| [13] |
Petrik J, Verbanac D, Fabijanec M, et al. Circulating tumor cells in colorectal cancer: detection systems and clinical utility [J]. Int J Mol Sci, 2022, 23(21)：13582.
|
| [14] |
Noubissi Nzeteu GA, Geismann C, Arlt A. Role of epithelial-to-mesenchymal transition for the generation of circulating tumors cells and cancer cell dissemination [J]. Cancers, 2022, 14(22)：5483.
|
| [15] |
Wu S, Liu S, Liu Z, et al. Classification of circulating tumor cells by epithelial-mesenchymal transition markers [J]. PloS One, 2015, 10(4)：e0123976.
|
| [16] |
Wu S, Liu Z, Liu S, et al. Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions [J]. Clin Chem Lab Med 2014, 52(2)：243-251.
|
| [17] |
Bartkowiak K, Mossahebi Mohammadi P, Gärtner S, et al. Detection and isolation of circulating tumor cells from breast cancer patients using CUB domain-containing protein 1 [J]. J Proteome Res, 2023, 22(4)：1213-1230.
|
| [18] |
Zhang W, Duan X, Zhang Z, et al. Combination of CT and telomerase＋ circulating tumor cells improves diagnosis of small pulmonary nodules [J]. JCI insight, 2021, 6(11)：e148182.
|
| [19] |
Lone SN, Nisar S, Masoodi T, et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments [J]. Mol Cancer, 2022, 21(1)：79.
|
| [20] |
Liu Z, Fusi A, Klopocki E, et al. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients [J]. J Transl Med, 2011, 9：70.
|
| [21] |
Zhang H, Lin X, Huang Y, et al. Detection methods and clinical applications of circulating tumor cells in breast cancer [J]. Front Oncol, 2021, 11：652253.
|
| [22] |
Banys-Paluchowski M, Krawczyk N, Fehm T. Liquid biopsy in breast cancer [J]. Geburtshilfe Frauenheilkd, 2020, 80(11)：1093-1104.
|
| [23] |
Xu J, Liao K, Yang X, et al. Using single-cell sequencing technology to detect circulating tumor cells in solid tumors [J]. Mol Cancer, 2021, 20(1)：104.
|
| [24] |
Lin D, Shen L, Luo M, et al. Circulating tumor cells: biology and clinical significance [J]. Signal Transduct Target Ther, 2021, 6(1)：404.
|
| [25] |
Korhonen KE, Zuckerman SP, Weinstein SP, et al. Breast MRI: false-negative results and missed opportunities [J]. Radiographics, 2021, 41(3)：645-664.
|
| [26] |
Guo R, Lu G, Qin B, et al. Ultrasound imaging technologies for breast cancer detection and management: a review [J]. Ultrasound Med Biol, 2018, 44(1)：37-70.
|
| [27] |
Donepudi MS, Kondapalli K, Amos SJ, et al. Breast cancer statistics and markers [J]. J Cancer Res Ther, 2014, 10(3)：506-511.
|
| [28] |
Song X, Liang B, Wang C, et al. Clinical value of color Doppler ultrasound combined with serum CA153, CEA and TSGF detection in the diagnosis of breast cancer [J]. Exp Ther Med, 2020, 20(2)：1822-1828.
|
| [29] |
Fu Y, Li H. Assessing clinical significance of serum CA15-3 and carcinoembryonic antigen (CEA) levels in breast cancer patients: a meta-analysis [J]. Med Sci Monit, 2016, 22：3154-3162.
|
| [30] |
Zhang J, Wei Q, Dong D, et al. The role of TPS, CA125, CA15-3 and CEA in prediction of distant metastasis of breast cancer [J]. Clin Chim Acta, 2021, 523：19-25.
|
| [31] |
Li J, Guan X, Fan Z, et al. Non-invasive biomarkers for early detection of breast cancer [J]. Cancers, 2020, 12(10)：2767.
|
| [32] |
Jin L, Zhao W, Zhang J, et al. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter((R)) CTC capture system in patients with breast cancer [J]. Cancer Med, 2020, 9(5)：1638-1647.
|
| [33] |
Alix-Panabières C, Pantel K. Challenges in circulating tumour cell research [J]. Nat Rev Cancer, 2014, 14(9)：623-631.
|
| [34] |
Meng S, Tripathy D, Frenkel EP, et al. Circulating tumor cells in patients with breast cancer dormancy [J]. Clin Cancer Res, 2004, 10(24)：8152-8162.
|
| [35] |
Werner S, Heidrich I, Pantel K. Clinical management and biology of tumor dormancy in breast cancer [J]. Semin Cancer Biol, 2022, 78：49-62.
|
| [36] |
Cieślikowski WA, Budna-Tukan J, Świerczewska M, et al. Circulating tumor cells as a marker of disseminated disease in patients with newly diagnosed high-risk prostate cancer [J]. Cancers, 2020, 12(1)：160.
|
| [37] |
Kruspe S, Dickey DD, Urak KT, et al. Rapid and sensitive detection of breast cancer cells in patient blood with nuclease-activated probe technology [J]. Mol Ther Nucleic Acids, 2017, 8：542-557.
|
| [38] |
Smerage JB, Barlow WE, Hortobagyi GN, et al. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500 [J]. J Clin Oncol, 2014, 32(31): 3483- 3489.
|
| [39] |
Bidard FC, Jacot W, Kiavue N, et al. Efficacy of circulating tumor cell count-driven vs clinician-driven first-line therapy choice in hormone receptor-positive, ERBB2-negative metastatic breast cancer: the STIC CTC randomized clinical trial [J]. JAMA Oncol, 2021, 7(1)：34-41.
|
| [40] |
Rack B, Zombirt E, Trapp E, et al. Comparison of HER2 expression in primary tumor and disseminated tumor cells in the bone marrow of breast cancer patients [J]. Oncology, 2016, 90(4)：232-238.
|
| [41] |
Jacot W, Cottu P, Berger F, et al. Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial [J]. Breast Cancer Res, 2019, 21(1)：121.
|
| [42] |
Rzhevskiy A, Kapitannikova A, Malinina P, et al. Emerging role of circulating tumor cells in immunotherapy [J]. Theranostics, 2021, 11(16)：8057-8075.
|
| [43] |
Goodman CR, Seagle BL, Friedl TWP, et al. Association of circulating tumor cell status with benefit of radiotherapy and survival in early-stage breast cancer [J]. JAMA Oncol, 2018, 4(8)：e180163.
|
| [44] |
Freitas AJA, Causin RL, Varuzza MB, et al. Liquid biopsy as a tool for the diagnosis, treatment, and monitoring of breast cancer [J]. Int J Mol Sci, 2022, 23(17)：9952.
|
| [45] |
Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J]. N Engl J Med, 2004, 351(8)：781-791.
|
| [46] |
Yin J, Wang Z, Li G, et al. Characterization of circulating tumor cells in breast cancer patients by spiral microfluidics [J]. Cell Biol Toxicol, 2019, 35(1)：59-66.
|
| [47] |
Heidrich I, Deitert B, Werner S, et al. Liquid biopsy for monitoring of tumor dormancy and early detection of disease recurrence in solid tumors [J]. Cancer Metastasis Rev, 2023, 42(1)：161-182.
|
| [48] |
Cristofanilli M, Pierga JY, Reuben J, et al. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper [J]. Crit Rev Oncol Hematol, 2019, 134：39-45.
|
| [49] |
Helissey C, Berger F, Cottu P, et al. Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: the observational step of the CirCe01 phase III trial [J]. Cancer Lett, 2015, 360(2)：213-218.
|
| [50] |
Fabisiewicz A, Szostakowska-Rodzos M, Zaczek AJ, et al. Circulating tumor cells in early and advanced breast cancer; biology and prognostic value [J]. Int J Mol Sci, 2020, 21(5)：1671.
|
| [51] |
Lucci A, Hall CS, Lodhi AK, et al. Circulating tumour cells in non-metastatic breast cancer: a prospective study [J]. Lancet Oncol, 2012, 13(7)：688-695.
|
| [52] |
Trapp E, Janni W, Schindlbeck C, et al. Presence of circulating tumor cells in high-risk early breast cancer during follow-up and prognosis [J]. J Natl Cancer Inst, 2019, 111(4)：380-387.
|